Literature DB >> 18205551

An optimized lentivirus-mediated RNAi screen reveals kinase modulators of kinesin-5 inhibitor sensitivity.

Richard A Klinghoffer1, Brian Roberts, James Annis, Jason Frazier, Patrick Lewis, Peter S Linsley, Michele A Cleary.   

Abstract

Abstract: Induction of RNA interference (RNAi) in human cells has enabled comprehensive functional annotation of the human genome via reverse genetic screens. Here we describe an optimized semiautomated method to produce, titrate, and screen large collections of short hairpin RNA (shRNA)-containing lentiviral vectors. We also present results from a pilot lentiviral RNAi screen for kinases whose silencing modulates sensitivity to a mitotic spindle protein kinesin-5 inhibitor (kinesin-5i). Our screen identified three distinct serine/threonine kinase 6 shRNA vectors within our library as enhancers of kinesin-5i-mediated HT29 cell growth inhibition. In contrast, three distinct shRNAs targeting cell division cycle 2/cyclin-dependent kinase 1 resulted in kinesin-5i resistance. These results demonstrate the feasibility of screening with large collections of lentiviral vectors to identify drug enhancers and suppressors.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18205551     DOI: 10.1089/adt.2007.106

Source DB:  PubMed          Journal:  Assay Drug Dev Technol        ISSN: 1540-658X            Impact factor:   1.738


  5 in total

1.  Reduced seed region-based off-target activity with lentivirus-mediated RNAi.

Authors:  Richard A Klinghoffer; Jill Magnus; Janell Schelter; Michele Mehaffey; Casey Coleman; Michele A Cleary
Journal:  RNA       Date:  2010-03-26       Impact factor: 4.942

2.  Investigation of RNA interference suppression of matrix metalloproteinase-9 in mouse model of atherosclerosis.

Authors:  Zhe-Xiu Jin; Qiang Xiong; Fang Jia; Chun-Ling Sun; Hong-Tao Zhu; Fu-Sheng Ke
Journal:  Int J Clin Exp Med       Date:  2015-04-15

Review 3.  RNAi mechanisms in Huntington's disease therapy: siRNA versus shRNA.

Authors:  Sebastian Aguiar; Bram van der Gaag; Francesco Albert Bosco Cortese
Journal:  Transl Neurodegener       Date:  2017-11-27       Impact factor: 8.014

4.  A multi-shRNA vector enhances the silencing efficiency of exogenous and endogenous genes in human cells.

Authors:  Yanjie Weng; Ying Shi; Xi Xia; Wenjuan Zhou; Hongyan Wang; Changyu Wang
Journal:  Oncol Lett       Date:  2017-02-02       Impact factor: 2.967

5.  A lentivirus-mediated genetic screen identifies dihydrofolate reductase (DHFR) as a modulator of beta-catenin/GSK3 signaling.

Authors:  Richard A Klinghoffer; Jason Frazier; James Annis; Jason D Berndt; Brian S Roberts; William T Arthur; Raul Lacson; Xiaohua Douglas Zhang; Marc Ferrer; Randall T Moon; Michele A Cleary
Journal:  PLoS One       Date:  2009-09-03       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.